![(3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine](https://static.cymitquimica.com/products/3D/img/IE22671.png "Cliccare per ingrandire")
(3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine
CAS: 76272-56-5
Rif. 3D-IE22671
| 2g | Prezzo su richiesta | ||
| 5g | Prezzo su richiesta | ||
| 10g | Prezzo su richiesta | ||
| 25g | Prezzo su richiesta | ||
| 50g | Prezzo su richiesta |
Informazioni sul prodotto
- b-3-Amino-9-methyl-9-azabicyclo[3.3.1]nonaneGranisetron impurity E (free base)
- Endo-3-Amine-9-Methyl-9-Azabicyclo[3,3,1]Nonane
- Endo-3-amino-9-methyl-9-azabicyclo[3,3,1]nonane
- Endo-9-Methyl-9-Azabicyclo[3,3,1] nonane-3-Amine
- 9-Methyl-9-Azabicyclo[3.3.1]Nonan-3-Amine
- 9-Methyl-9-Azabicyclo[3.3.1]Nonan-1-Amine
Granisetron is a drug that belongs to the group of serotonin receptor antagonists. It is used as an antiemetic, mainly in the prevention and treatment of nausea and vomiting caused by cancer chemotherapy and surgery. This drug has been shown to be effective in controlling nausea and vomiting, even when given after chemotherapy or surgical procedures. Granisetron hydrochloride was synthesized in 1988 by chemists at Hoffmann-La Roche. The synthesis was patented in 1990. Potential impurities are not listed on the USP or EP pharmacopeia, but these impurities have been detected during synthesis.
Proprietà chimiche
Richiesta tecnica su: 3D-IE22671 (3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
